Publications by authors named "Craig A Martin"

Claim this Profile
I
Impact of PhORCAS references on overall application score for postgraduate year 1 pharmacy residency candidates.
Sara A Atyia, Frank P Paloucek, Allison R Butts, Douglas R Oyler, Craig A Martin

Am J Health Syst Pharm· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of β-Lactam Infusion Strategy on Acute Kidney Injury.
Sarah E Cotner, W Cliff Rutter, Donna R Burgess, Katie L Wallace, Craig A Martin

Antimicrob Agents Chemother· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephrotoxicity in Patients with or without Cystic Fibrosis Treated with Polymyxin B Compared to Colistin.
Ryan L Crass, W Cliff Rutter, Donna R Burgess, Craig A Martin, David S Burgess

Antimicrob Agents Chemother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum for Rutter et al., Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
W Cliff Rutter, Jessica N Cox, Craig A Martin, Donna R Burgess, David S Burgess

Antimicrob Agents Chemother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.
Benjamin J Ereshefsky, Majdi N Al-Hasan, Yevgeniya Gokun, Craig A Martin

J Chemother· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
W Cliff Rutter, Jessica N Cox, Craig A Martin, Donna R Burgess, David S Burgess

Antimicrob Agents Chemother· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients.
R Zachary Thompson, Craig A Martin, Donna R Burgess, W Cliff Rutter, David S Burgess

J Cyst Fibros· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing Monte Carlo Simulations to Optimize Institutional Empiric Antipseudomonal Therapy.
Sarah J Tennant, Donna R Burgess, Jeffrey M Rybak, Craig A Martin, David S Burgess

Antibiotics (Basel)· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
Jeffrey M Rybak, Kayleigh Marx, Craig A Martin

Pharmacotherapy· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulminant Invasive Pulmonary Aspergillosis After a Near-Drowning Accident in an Immunocompetent Patient.
Kelley L Ratermann, Benjamin J Ereshefsky, Elise L Fleishaker, Alice C Thornton, Ketan P Buch, Craig A Martin

Ann Pharmacother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness.
A Kendall Gross, Steven P Dunn, David J Feola, Craig A Martin, Richard Charnigo

J Thromb Thrombolysis· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of a 24-hour inhouse on-call program for pharmacy residents.
Kevin W McConeghy, P Shane Winstead, Aaron M Cook, Craig A Martin, Kyle A Weant

Am J Health Syst Pharm· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole.
Don Hayes, Amanda M Ball, Heidi M Mansour, Craig A Martin, Jeremy D Flynn

Exp Clin Transplant· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Web-based experiential rotation platform.
Aaron M Cook, Dan A Lewis, Craig A Martin

Am J Health Syst Pharm· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving antimicrobial stewardship from restriction to facilitation.
Craig A Martin, John A Armitstead, Ryan P Mynatt, Ardis D Hoven

Am J Health Syst Pharm· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidemia incidence in recipients of parenteral nutrition.
Rachel C Stratman, Craig A Martin, Robert P Rapp, Rolando Berger, Barbara Magnuson

Nutr Clin Pract· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a pharmacist-to-dose computerized request on promptness of antimicrobial therapy.
William R Vincent, Craig A Martin, P Shane Winstead, Kelly M Smith, Jennifer Gatz

J Am Med Inform Assoc· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico.
Craig A Martin, Kazumi Morita, Julie A Ribes, Lalitagauri M Deshpande, Helio S Sader

Antimicrob Agents Chemother· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selecting anti-infective agents for the treatment of bone infections: new anti-infective agents and chronic suppressive therapy.
Veena Venugopalan, Craig A Martin

Orthopedics· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which hydroxy? Evidence for species differences in the regioselectivity of glucuronidation in rat, dog, and human in vitro systems and dog in vivo.
Iain J Martin, Richard J Lewis, Michael A Bernstein, Iain G Beattie, Craig A Martin

Drug Metab Dispos· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhabdomyolysis during therapy with daptomycin.
Stella Papadopoulos, Amanda M Ball, Susanne E Liewer, Craig A Martin, P Shane Winstead

Clin Infect Dis· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Meredith B Toma, Kelly M Smith, Craig A Martin, Robert P Rapp

Orthopedics· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infection.
Aaron M Cook, Christian N Ramsey, Craig A Martin, Thomas Pittman

Pediatr Neurosurg· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
Shellee A Grim, Robert P Rapp, Craig A Martin, Martin E Evans

Pharmacotherapy· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rash associated with piperacillin/tazobactam administration in infectious mononucleosis.
Aimée C LeClaire, Craig A Martin, Ardis D Hoven

Ann Pharmacother· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis